A. Zhang et al. / Tetrahedron Letters 51 (2010) 828–831
831
4. Cyclization with Burgess reagent: (a) Li, J. J.; Li, J. J.; Li, J.; Trehan, A. K.; Wong, H.
S.; Krishnananthan, S.; Kenedy, L. J.; Gao, Q.; Ng, A.; Robl, J. A.;
Balasubramanian, B.; Chen, B.-C. Org. Lett. 2008, 10, 2897; Cyclization with
POCl3: (b) Bower, J. D.; Ramage, G. R. J. Chem. Soc. 1955, 2834; Cyclization with
polyphosphoric acid: (c) Winterfeld, K.; Franzke, H. Angew. Chem. 1963, 75,
1101; Cyclization of thioamide with DCC: (d) Bourdais, J.; Omar, A.-M. M. E. J.
Heterocycl. Chem. 1980, 17, 555; Cyclization of thioamide with Hg(II) salt: (e) El
Khadem, H. S.; Kawai, J.; Swartz, D. L. Heterocycles 1989, 28, 239; Cyclization of
thioamide with I2: (f) Shibahara, F.; Kiagawa, A.; Yamaguchi, E.; Murai, T. Org.
Lett. 2006, 8, 5621.
5. Crawforth, J. M.; Paoletti, M. Tetrahedron Lett. 2009, 50, 4916.
6. Copper catalyzed oxidation with oxygen: (a) Bluhm, M. E.; Ciesielski, M.; Gorls,
H.; Doring, M. Angew. Chem., Int. Ed. 2002, 41, 2962; Oxidation with sulfur: (b)
Shibahara, F.; Sugiura, R.; Yamaguchi, E.; Kitagawa, A.; Murai, T. J. Org. Chem.
2009, 74, 3566.
7. (a) Beebe, X.; Gracias, V.; Djuric, S. W. Tetrahedron Lett. 2006, 47, 3225; (b)
Katritzky, A. R.; Qiu, G. J. Org. Chem. 2001, 66, 2862; (c) Wang, J.; Dyers, L., Jr.;
Mason, R., Jr.; Amoyaw, P.; Bu, X. R. J. Org. Chem. 2005, 70, 2353.
8. (a) Wang, L.; Shen, W. Tetrahedron Lett. 1998, 39, 7625; (b) Shen, W.; Wang, L. J.
Org. Chem. 1999, 64, 8873; (c) Shen, W.; Thomas, S. A. Org. Lett. 2000, 2, 2857;
(d) Shen, W. Synlett 2000, 737.
9. (a) Shen, W.; Kunzer, A. Org. Lett. 2002, 4, 1315; (b) Huh, D. H.; Jeong, J. S.; Lee,
H. B.; Ryn, H.; Kim, Y. G. Tetrahedron 2002, 58, 9925.
10. Huh, D. H.; Ryu, H.; Kim, Y. G. Tetrahedron 2004, 60, 9857.
11. Shen, W.; Kohn, T.; Fu, Z.; Jiao, X.-Y.; Lai, S.; Schmitt, M. Tetrahedron Lett. 2008,
49, 7284.
methoxyquinoline (2f) afforded good yield of the desired product
(3f) without the corresponding amide. Neutral substitutions at
positions other than ‘C-6’ of 2-aminomethylpyridine are well toler-
ated (Table 2, entries 3, 4, 14).
Substitutions on the aryl ring of 2-aryl-1,1-dibromoethene are
well tolerated, as both electron-donating (1d) and electron-with-
drawing (1a, 1c) substrates gave good yields of the corresponding
products. Heteroaromatic substitutions (1b, 1c) are also tolerated.
Bromine substitution on aryl ring (1f) does not affect the reaction,
while it may provide a handle for further manipulation of the result-
ing product (3m). Finally, an ester group in place of aryl ring gave
good yields of products (entries 13 and 14). This would broaden
the scope of this reaction.
In summary, a facile synthesis of imidazo[1,5-a]pyridines is de-
scribed. This method employs a mild inorganic base and moderate
heating, which are different from existing reaction conditions for
the preparation of this class of compounds. Therefore, the method
should complement the existing synthesis of imidazo[1,5-a]pyri-
dines, and will find applications in both synthetic organic and
medicinal chemistry.
12. Besides di(isopropyl)ethylamine (DIEA) and DABCO, 4-methylmorpholine,
DBU, tetramethylguanidine also failed to give good yields of the desired
product.
Acknowledgments
13. The nucleophilicity of pyridinyl ‘N’ is parallel to its basicity: 2-
Methoxypyridine is a significantly weaker base than pyridine or 2-methy
pyridine (pKa’s are 3.3 for 2-methoxypyridine, 5.2 for pyridine, and 6.0 for 2-
methylpyridine): Joule, J. A.; Mills, K. Heterocyclic Chemistry, 4th ed.; Blackwell:
Oxford, 2000. Chapter 5.
The authors are grateful to Jack Maung for proof reading of this
manuscript.
14. Typical reaction procedure: A mixture of methyl 4-(2,2-dibromovinyl)benzoate
(1a, 320 mg, 1.0 mmol) and 2-aminomethylpyridine (2a, 119 mg, 1.1 mmol) in
DMF (5 mL) and Na2CO3 (1.0 M, 2.0 mmol) was heated at 80 °C for 20 h. The
reaction mixture was cooled to room temperature, diluted with ethyl acetate
(80 mL), washed with water (10 mL) and brine (5 mL), dried over anhyd
Na2SO4, and concentrated. The residue was subjected to silica gel
chromatography using 10% methanol in dichloromethane to give methyl 4-
(imidazo[1,5-a]pyridin-3-ylmethyl)benzoate (3a, 184 mg, 69%). 1H NMR
(CDCl3, 300 MHz) d 7.96 (d, J = 8.1 Hz, 2H),7.56 (d, J = 7.5 Hz, 1H), 7.44 (t,
J = 4.4 Hz, 2H), 7.26 (d, J = 8.1 Hz, 2H), 6.66 (t, J = 7.8 Hz, 1H), 6.47 (t, J = 6.8 Hz,
1H), 4.49 (s, 2H), 3.90 (s, 3H); LC–MS (ESI+) m/z: 267 (M+H).
References and notes
1. Reviews: (a) Hamama, W. S.; Zoorob, H. H. Tetrahedron 2002, 58, 6143; (b)
Swinbourne, J. F.; Hunt, H. J.; Klinkert, G. Adv. Heterocycl. Chem. 1979, 23, 103.
2. Isolation and characterization of cribrostatin-6: (a) Pettit, G. R.; Collins, J. C.;
Knight, J. C.; Herald, D. L.; Nieman, R. A.; Williams, M. D.; Pettit, R. K. J. Nat. Prod.
2003, 66, 544; A recent total synthesis: (b) Knueppel, D.; Martin, S. F. Angew.
Chem., Int. Ed. 2009, 48, 2569.
3. As thromboxane synthetase inhibitor: (a) Brännström, K.; Arendshorst, W. J.
Am. J. Physiol. 1999, 276, F758; b As Mek Kinase inhibitor: Price, S.; Heald, R.;
Savy, P. P. A. WO2009085980, 2009. Chem. Abstr. 2009, 151, 123,970.